Log in or Sign up for Free to view tailored content for your specialty!
Cirrhosis/Liver Failure News
Non-invasive MRI for liver disorders receives expanded FDA clearance
Perspectum Diagnostics Ltd. received 510(k) clearance from the FDA for LiverMultiScan, a post-processing software device for MRI of the liver, which will expand its access to more patients with liver disorders who can benefit from non-invasive diagnostic aid, according to a press release.
Drinking coffee reduces risk for death, negative health outcomes
Consuming coffee lowered the risk for death and a broad spectrum of health outcomes, according to a report recently published in BMJ.
Log in or Sign up for Free to view tailored content for your specialty!
Moderate coffee intake reduces risk for liver cancer, cirrhosis, fibrosis
In a roundtable format, experts gathered to discuss the latest research on coffee and liver disease, which indicate that drinking approximately three to five cups per day is associated with a reduced risk for hepatocellular carcinoma, cirrhosis and fibrosis.
Bacterial infections frequently occur in acute-on-chronic liver failure
In a recent study, two-thirds of patients with acute-on-chronic liver failure either presented with bacterial infections or developed them during follow-up, revealing that such infections are significantly common in this cohort.
Model accurately predicts cirrhosis-driven hepatic encephalopathy
A recently published study reports on the development of two risk-score models to predict the 1-year and 5-year probability for hepatic encephalopathy in patients with cirrhosis, based on statin use and total bilirubin and albumin.
Psoriasis, inflammatory diseases increase risk for cirrhosis, fatty liver
Patients with inflammatory disorders, especially psoriasis and psoriatic arthritis, had an elevated risk for severe liver disease such as nonalcoholic fatty liver disease and cirrhosis, according to a recently published study.
VIDEO: Expert reviews promising treatment data from The Liver Meeting 2017
WASHINGTON, D.C. — In this exclusive video from The Liver Meeting 2017, Kris V. Kowdley, MD, FAASLD, of the Swedish Medical Center, Liver Care Network, Seattle, highlights some of the ground-breaking presentations from the meeting.
VIDEO: Alcohol misuse, related cirrhosis increasing in U.S.
WASHINGTON — In this exclusive video from The Liver Meeting 2017, Jessica L. Mellinger, MD, from the department of Internal Medicine-Hepatology at the University of Michigan, discusses the increasing rates of alcohol use disorders and alcoholic cirrhosis in the U.S.
Mobile monitoring reduces preventable cirrhosis readmissions
WASHINGTON — A novel mobile device monitoring system reduced 30- and 90-day cirrhosis-related readmissions with no potentially preventable readmissions in this pilot study at 90 days, according to data presented at The Liver Meeting 2017.
Early liver transplant in severe alcoholic hepatitis shows benefit
WASHINGTON — Early liver transplant in patients with severe alcoholic hepatitis demonstrated acceptable short-term survival, according to results from the multi-center ACCELERATE-AH study presented at The Liver Meeting 2017.